Statistically Significant Results For TC-5619 On Measures Of Cognitive Dysfunction In Schizophrenia And Negative Symptoms Of Schizophrenia

Links shared publicly online about this topic.

  • 380
    total visits

Statistically Significant Results For TC-5619 On Measures Of Cognitive Dysfunction In Schizophrenia And Negative Symptoms Of Schizophrenia

medicalnewstoday.com —

Targacept, Inc. (NASDAQ: TRGT) today announced the presentation of data from a Phase 2 clinical proof of concept trial to assess TC-5619 as an augmentation therapy to improve cognition in patients

View full resource at medicalnewstoday.com

Tags: Schizophrenia, Psychotic Disorder

  • Share

Most Recently Shared on April 8, 2011 at 2:05 pm By:

HealthPassion HealthPassion

Statistically Significant Results For TC-5619 On Measures Of Cognitive Dysfunction In Schizophrenia And Negative... http://bit.ly/hApbER

1 year ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Schizophrenia MNT Schizophrenia

MNT Mental Health MNT Mental Health

Advertisement